{"id":727064,"date":"2023-01-31T07:09:21","date_gmt":"2023-01-31T12:09:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/"},"modified":"2023-01-31T07:09:21","modified_gmt":"2023-01-31T12:09:21","slug":"polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/","title":{"rendered":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PETACH TIKVA,\u00a0Israel, Jan.  31, 2023  (GLOBE NEWSWIRE) &#8212; PolyPid Ltd.\u00a0(Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on\u00a0Wednesday, February 8, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time\u00a0to discuss the results and provide an update on business operations.<\/p>\n<p align=\"justify\">To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.<\/p>\n<p>\n        <strong>Conference Call Dial-In &amp; Webcast Information:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:19%;width:19%;min-width:19%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Date:<\/td>\n<td style=\"max-width:81%;width:81%;min-width:81%;vertical-align: middle\">Wednesday, February 8, 2023<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Time:<\/td>\n<td style=\"vertical-align: middle\">8:30 AM Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Conference Call:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/register.vevent.com\/register\/BIdad8bd318dec4d3cb9437ab9c40bd263\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/register.vevent.com\/register\/BIdad8bd318dec4d3cb9437ab9c40bd263<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Webcast:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/rak4fxxm\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/rak4fxxm<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About\u00a0PolyPid<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ih2XZprDpXUfP2jpdlTVMDPzE44Np2wJo-y9E488hOPuAvs6gfwF_RDR2l935p65x3VYhdF6YVB8lOtWuB3ZH0oTJUEnTc1v-nIZ5JTLrxgyxClIn-XTGQRnSwwlS27a4HbAyfvDtzFuGumiPZTCIoWnTLsuyL7137gqY1JETKAtu0JP7_NPmXrQsGsFzlj3OY53LhFcfHJpFOHKtIoo9fbhe107hAEQo4vtDcvZd4w=\" rel=\"nofollow noopener\" target=\"_blank\">PolyPid Ltd.<\/a>\u00a0(Nasdaq:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yQpxvoLjxpAlcIg5us6SFM369Qw5ixV_1uPAnShOfQa-OqwV6eV3yGToN_Ovm-uqqSvvAIcKVH3WRcMm_o1MovvAeMPa578G-xe9YC7M__oU8LZYGvE_W776SIEPtwab24J3PB12OkHZWgwWVKnVdl0vpNAn3KG2AcdYkGaOJgxO00CQcMDxQhwNnRnaNX_P2UAyoIfEbGulNHYkAXL0tffCygjkUKWfeIkt2yJ9Vuxeijs7kSSRfZgXmGQiInaM\" rel=\"nofollow noopener\" target=\"_blank\">PYPD<\/a>) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid\u2019s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid\u2019s lead product candidate D-PLEX<sub>100<\/sub>\u00a0is in Phase 3 clinical trials for the prevention of soft tissue abdominal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for treatment of solid tumors, beginning with glioblastoma.<\/p>\n<p align=\"justify\">For additional Company information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yA1_Mn8dk0LWTvb2vtCgoG2hQQ_vRHrPBBHjkEzLBr_R3BNsFS52lig5UHfVGKWu3dDXhv92uLPwraSyV7AWmzRt4Ed516xiqw6OUHCbFl0gAXSKvmK4DaZHjgfFPpy0Lv7p-TcfDnj1tcxiQW_jhu_OvzGqgFnfNp0UiNEK1U1hVi2yFHbRLV2tfc9GgHA3aaN7J0BH1qUMH8eSVqSX2Sfss7JuMKMXFuf0fkjEzQDorrNtlR1COlU2RaI_qozi75EfYY7pxtg02KQvJmiRGw==\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.polypid.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8b4LC4KPv4YbsL9VAA7GlYiq8GhwnbM3-cW1D5qKHmCqZLb9QZr0W6nzW8xDu32HyL6iMVXK0yGh7O8uzwVmvhSzaJpPPifLTcHSsYHd43MCudYet_fTBzu4OrR3hvx1f3L9YzCLYtBgpcxnIJp66IF58PKjg0lcxM5xQtG4w49gnoD2VHkuJF1TWGWlN7SMd3klsOeyDH9ztmZcUabi6Q==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=esQSzytdxsPKNL0_d_XZ8nA7skLBK9PPZJRZ1ZpjNXgPvuDRVLabNk9-Nk3bmAPkgfupHJ2fRhRhbrP4eMd-Y1fmvEvGYdI2js1xsFD_FFWoTk1ZgaqoQpiIjksrAfezzJbMkHPah06PTSYiXb7G_y0jtuSU_hthOJEhGJkfMFUiAoQb18YsNxj0DHF04H-DQglfl1XEC9BhUCIPdJM7DQuMy262xPurEaD5Prb_F3J6sLKIfiaRtku3iGrHKQy8_pEC0-nkrYdmai3ZZpbwvg==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.\u00a0PolyPid\u00a0is not responsible for the contents of third-party websites.<\/p>\n<p>\n        <strong>Contacts:\u00a0<\/strong><\/p>\n<p>PolyPid Ltd. <br \/>Ori Warshavsky<br \/>COO \u2013 US<br \/>908-858-5995<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w25WfSyFLDrZLzG0p_sJcSNRXUrY1Nv5qDQ5ctHyspYjC7rVtQ8DfVwqR6boqlUSA-a3PLk4Rr5vI_vo-l_ZSg==\" rel=\"nofollow noopener\" target=\"_blank\">IR@Polypid.com<\/a><\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Brian Ritchie<br \/>LifeSci Advisors<br \/>212-915-2578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nOKRjYsNRVhJ38_6M7T3l67vQYBrlTchOKwaEH_l5ZBHwKf-4acaNPAx0GZ1ZeTAyLMKH44ZgrRr8T8XKNsI3fM05KqSAW0FQOpXX9okDTHqgPdXhRCFFYWW_Uu1t1fU\" rel=\"nofollow noopener\" target=\"_blank\">Britchie@lifesciadvisors.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWRmZGYyNDYtYjExMS00NmE4LWJjNmQtYzE0MGFmYWJlZjU2LTEwMjgxOTE=\/tiny\/PolyPid-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PETACH TIKVA,\u00a0Israel, Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd.\u00a0(Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on\u00a0Wednesday, February 8, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time\u00a0to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727064","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PETACH TIKVA,\u00a0Israel, Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd.\u00a0(Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on\u00a0Wednesday, February 8, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time\u00a0to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the &hellip; Continue reading &quot;PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T12:09:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023\",\"datePublished\":\"2023-01-31T12:09:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/\",\"name\":\"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\",\"datePublished\":\"2023-01-31T12:09:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/","og_locale":"en_US","og_type":"article","og_title":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk","og_description":"PETACH TIKVA,\u00a0Israel, Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; PolyPid Ltd.\u00a0(Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on\u00a0Wednesday, February 8, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time\u00a0to discuss the results and provide an update on business operations. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the &hellip; Continue reading \"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T12:09:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023","datePublished":"2023-01-31T12:09:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/"},"wordCount":342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/","name":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=","datePublished":"2023-01-31T12:09:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTU5MiM1MzgxMjI0IzIwMTY2MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727064"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}